Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozenoxacin 1% Cream for Impetigo
NCT02090764Phase 3Completed
- Sponsor
- Ferrer
- Start
- Jun 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozenoxacin in impetigo, sponsored by Ferrer. Started Jun 2014; status: completed.
02
Drugs
ozenoxacin
03
Conditions
impetigo
Beyond the preview
Go deeper on NCT02090764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090764.